These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 34479584

  • 21. Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib.
    Correia CE, Bhattacharya K, Lee PJ, Shuster JJ, Theriaque DW, Shankar MN, Smit GP, Weinstein DA.
    Am J Clin Nutr; 2008 Nov; 88(5):1272-6. PubMed ID: 18996862
    [Abstract] [Full Text] [Related]

  • 22. Glycogen Storage Disease type IA refractory to cornstarch: Can next generation sequencing offer a solution?
    Steg Saban O, Pode-Shakked B, Abu-Libdeh B, Granot M, Barkai G, Haberman Y, Roterman I, Lahad A, Shouval DS, Weiss B, Marek-Yagel D, Barel O, Loberman-Nachum N, Abraham S, Somech R, Weinstein DA, Anikster Y.
    Eur J Med Genet; 2022 Jun; 65(6):104518. PubMed ID: 35550444
    [Abstract] [Full Text] [Related]

  • 23. Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre.
    Halligan RK, Dalton RN, Turner C, Lewis KA, Mundy HR.
    Orphanet J Rare Dis; 2022 May 12; 17(1):195. PubMed ID: 35549996
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. How many forms of glycogen storage disease type I?
    Veiga-da-Cunha M, Gerin I, Van Schaftingen E.
    Eur J Pediatr; 2000 May 12; 159(5):314-8. PubMed ID: 10834514
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Continuous glucose monitoring in children with glycogen storage disease type I.
    Hershkovitz E, Rachmel A, Ben-Zaken H, Phillip M.
    J Inherit Metab Dis; 2001 Dec 12; 24(8):863-9. PubMed ID: 11916320
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia.
    Zhou J, Waskowicz LR, Lim A, Liao XH, Lian B, Masamune H, Refetoff S, Tran B, Koeberl DD, Yen PM.
    Thyroid; 2019 Aug 12; 29(8):1158-1167. PubMed ID: 31337282
    [Abstract] [Full Text] [Related]

  • 32. Serum lipid and lipoprotein profile of patients with glycogen storage disease types I, III and IX.
    Geberhiwot T, Alger S, McKiernan P, Packard C, Caslake M, Elias E, Cramb R.
    J Inherit Metab Dis; 2007 Jun 12; 30(3):406. PubMed ID: 17407002
    [Abstract] [Full Text] [Related]

  • 33. Hypercalcemia in glycogen storage disease type I patients of Turkish origin.
    Kasapkara CS, Tümer L, Okur I, Eminoğlu T, Ezgü FS, Hasanoğlu A.
    Turk J Pediatr; 2012 Jun 12; 54(1):35-7. PubMed ID: 22397040
    [Abstract] [Full Text] [Related]

  • 34. Novel variants in Turkish patients with glycogen storage disease.
    Çakar NE, Gezdirici A, Topuz HŞ, Önal H.
    Pediatr Int; 2020 Oct 12; 62(10):1145-1150. PubMed ID: 32374048
    [Abstract] [Full Text] [Related]

  • 35. Mutation spectrum of glycogen storage disease type Ia in Tunisia: implication for molecular diagnosis.
    Barkaoui E, Cherif W, Tebib N, Charfeddine C, Ben Rhouma F, Azzouz H, Ben Chehida A, Monastiri K, Chemli J, Amri F, Ben Turkia H, Abdelmoula MS, Kaabachi N, Abdelhak S, Ben Dridi MF.
    J Inherit Metab Dis; 2007 Nov 12; 30(6):989. PubMed ID: 18008183
    [Abstract] [Full Text] [Related]

  • 36. A preliminary study of telemedicine for patients with hepatic glycogen storage disease and their healthcare providers: from bedside to home site monitoring.
    Hoogeveen IJ, Peeks F, de Boer F, Lubout CMA, de Koning TJ, Te Boekhorst S, Zandvoort RJ, Burghard R, van Spronsen FJ, Derks TGJ.
    J Inherit Metab Dis; 2018 Nov 12; 41(6):929-936. PubMed ID: 29600495
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hepatocyte transplantation for glycogen storage disease type Ib.
    Lee KW, Lee JH, Shin SW, Kim SJ, Joh JW, Lee DH, Kim JW, Park HY, Lee SY, Lee HH, Park JW, Kim SY, Yoon HH, Jung DH, Choe YH, Lee SK.
    Cell Transplant; 2007 Nov 12; 16(6):629-37. PubMed ID: 17912954
    [Abstract] [Full Text] [Related]

  • 39. Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk.
    Nagasaka H, Hirano K, Ohtake A, Miida T, Takatani T, Murayama K, Yorifuji T, Kobayashi K, Kanazawa M, Ogawa A, Takayanagi M.
    Eur J Pediatr; 2007 Oct 12; 166(10):1009-16. PubMed ID: 17206455
    [Abstract] [Full Text] [Related]

  • 40. Safety and Efficacy of Chronic Extended Release Cornstarch Therapy for Glycogen Storage Disease Type I.
    Ross KM, Brown LM, Corrado MM, Chengsupanimit T, Curry LM, Ferrecchia IA, Porras LY, Mathew JT, Weinstein DA.
    JIMD Rep; 2016 Oct 12; 26():85-90. PubMed ID: 26303612
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.